Table 2 Results from studies assessing the use and safety of IVUS re-entry devices. *Result includes data for outback re-entry device ** Conference abstract (Krishnamurthy et al., 2010; Baker et al., 2015; Al-Ameri et al., 2009; Scheinert et al., 2005; Vuruskan & Saracoglu, 2017; Zambrano et al., 2014; Smith et al., 2011; Saketkhoo et al., 2004; Arslan et al., 2014; Saket et al., 2004; Kickuth et al., 2006; Massimi et al., 2013; Gandini et al., 2015)

Saketkhoo et al. 2004 (Rocha-Singh et al., 2014)

6

6 (100)

64–85

2 SFA, 4 CIA

0 (0)

Saket et al. 2004 (Krishnamurthy et al., 2010)

7

7 (100)

73.4

3 FPA, 4 iliac

0 (0)

Scheinert D et al. 2005 (Moher et al., 2009) **

25

25 (100)

63

SFA

0 (0)

Jacobs et al. 2006 (Saketkhoo et al., 2004)

21 (20 patients)

21 (100)

61*

18 iliac, 3 SFA

4 (18)

Kickuth R et al 2006 [German] (Baker et al., 2015)

12 (5 CTOs, 7 aortic dissection)

12 (100)

64.6 ± 12.0

2 CIA, 3 SFA

0 (0)

Al-Ameri et al. 2009 (Arslan et al., 2014)

21

20 (95)

n/a

CIA, SFA

1 (5)

Krishnamurphy et al. 2010 (Vuruskan & Saracoglu, 2017)

11

11 (100)

69.8 ± 2.1

Iliac - 7 CIA, 1 EIA, 3 CIA and EIA

n/a

Smith et al. 2011 (Saket et al., 2004)

8

8 (100)

58.5

SFA

0 (0)

Massimi et al. 2013 (Scheinert et al., 2005) **

36 (72 RED)

69 (96)

n/a

Iliac

n/a

Zambrano et al. 2014 (Kickuth et al., 2006) **

42 (36 patients)

39 (93)

65 (46–86)

5 CIA, 1 EIA, 33 SFA, 3 IPA

2 (5)

Gandini et al. 2015 (Al-Ameri et al., 2009) **

20

18 (90)

n/a

SFA

0 (0)

Baker et al. 2015 (Smith et al., 2011)

20

18 (90)

69 ± 13 years

10 CIA, 3 EIA, 5 SFA

0 (0)

Arslan et al. 2015 (Massimi et al., 2013) **

7

7 (100) *

n/a

lower extremities

0 (0)*

Vuruskan et al. 2016 (Zambrano et al., 2014)

31

30 (96.7)

62.1 ± 9.2*

CIA, EIA, SFA, popliteal

8 (25.8)*

Kokkinidis et al. 2019 (Kokkinidis et al., 2020)

28

(90) *

63.9 (10.9)*

CIA

2 (5)*

Sheikh et al. (2021) (Sheikh et al., 2021)

135

118 (87.4)

70.1 ± 9.4

Iliac and femoropopliteal

(9.6)